treatment adenocarcinoma cardia synchron chemotherapi radiotherapi twenty-nin evalu patient adenocarcinoma cardia chemotherapi cycl cisplatin Gy radiat tumour respons treatment complet regress tumour patient partial regress fourteen patient tumour microscop tumour specimen nine patient addit radiotherapi total dose Gy surgeri respons rapid revers dysphagia patient subsequ intervent relief dysphagia due fibrou strictur enhanc surviv complet endoscop respons initi chemotherapi radiotherapi tumour cm length median surviv patient month synchron chemotherapi radiotherapi major palli benefit seri merit evalu 